ClassID:

21647

A61K2300/00 - page 46 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#13501
20090285785
2009-11-19

External Agent for Treatment of Skin Ulcer

#13502
20090285778
2009-11-19

USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER

#13503
20090285776
2009-11-19

Irreversibly-inactivated pepsinogen fragments for modulating immune function

#13504
20090285775
2009-11-19

TREATMENT OF WOUNDS USING IL-17B

#13505
20090285757
2009-11-19

METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY

#13506
20090281285
2009-11-12

Binding member which binds to both Lewis-and Lewis-haptens, and its use for treating cancer

#13507
20090281197
2009-11-12

Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis

#13508
20090281196
2009-11-12

1-adamantyl chalcones for the treatment of proliferative disorders

#13509
20090281194
2009-11-12

Combinations for treating HIV-associated pain

#13510
20090281186
2009-11-12

Composition and Method for Reducing Stress

#13511
20090281143
2009-11-12

Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity

#13512
20090281132
2009-11-12

Pharmaceutical formulation for use in hiv therapy

#13513
20090281114
2009-11-12

INDOLYLALKYL DERIVATIVES OF PYRIMIDINYLPIPERAZINE AND METABOLITES THEREOF FOR TREATMENT OF ANXIETY, DEPRESSION, AND SEXUAL DYSFUNCTION

#13514
20090281112
2009-11-12

ADATANSERIN AND METABOLITES THEREOF FOR TREATMENT OF ATTENTION DEFICIT DISORDER, ANXIETY, DEPRESSION, SEXUAL DYSFUNCTION, AND OTHER DISORDERS

#13515
20090281111
2009-11-12

3-HYDROXY GEPIRONE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER AND SEXUAL DYSFUNCTION

#13516
20090281106
2009-11-12

PROPHYLACTIC AND/OR THERAPEUTIC METHOD FOR RHEUMATOID ARTHRITIS

#13517
20090281105
2009-11-12

RADIOTHERAPY ENHANCER

#13518
20090281083
2009-11-12

Combination Product

#13519
20090281078
2009-11-12

COMBINATION OF SABCOMELINE WITH A NEUROLEPTIC AGENT TO TREAT PSYCHOTIC DISORDERS

#13520
20090281047
2009-11-12

Compositions And Methods For Immunotherapy

#13521
20090281021
2009-11-12

Composition and method for treating iron deficiency anemia

#13522
20090280203
2009-11-12

Compositions of atomized or lyophilized maca () extracts and atomized or lyophilized yacon () extracts as adjuvants in the treatment of different conditions

#13523
20090280200
2009-11-12

HERBAL EXTRACTS WHICH INDUCE IMMUNE CELLS TO PRODUCE INTERFERON AND ACTIVATE TOLL-LIKE RECEPTORS

#13524
20090280199
2009-11-12

Neuroprotective Compositions and Methods of Using Same

#13525
20090280198
2009-11-12

Combined effects of nutrients on proliferation of stem cells

#13526
20090280184
2009-11-12

Pharmaceutical composition, method of preparation and methods of treating aches/pains

#13527
20090280177
2009-11-12

Pharmaceutical preparation for treating fibromyalgia

#13528
20090280164
2009-11-12

THERAPY FOR HUMAN CANCERS USING CISPLATIN AND OTHER DRUGS OR GENES ENCAPSULATED INTO LIPOSOMES

#13529
20090280130
2009-11-12

METHOD FOR THE TREATMENT OF ANTHRAX TOXICITY

#13530
20090280122
2009-11-12

USE OF A VIRUS REGIMEN FOR THE TREATMENT OF DISEASES

#13531
20090280115
2009-11-12

Dihydropteridinones in the Treatment of Respiratory Diseases

#13532
20090280112
2009-11-12

INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS

#13533
20090280109
2009-11-12

ILT3 and ILT4-related compositions and methods

#13534
20090280103
2009-11-12

REGULATION OF MUSCLE REPAIR

#13535
20090280102
2009-11-12

Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof

#13536
20090280087
2009-11-12

Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyanin

#13537
20090280085
2009-11-12

Long Acting Human Interferon Analogs

#13538
20090280084
2009-11-12

Nucleoside derivatives for treatment of infections, including Norovirus infections

#13539
20090280078
2009-11-12

Cosmetic composition to accelerate repair of functional wrinkles

#13540
20090280062
2009-11-12

LONGEVITY-PROMOTING EFFECTS OF ACETIC ACID AND REISHI POLYSACCHARIDE

#13541
20090277843
2009-11-12

Polymer composite, water-treatment method using the same and manufacturing method of the same

#13542
20090275872
2009-11-05

Fluid wound dressing comprising partially cured polyurethane

#13543
20090275670
2009-11-05

DOG PHEROMONE FORMULATION AND DELIVERY SYSTEM

#13544
20090275657
2009-11-05

Fatty acid antimicrobial

#13545
20090275629
2009-11-05

THERAPY FOR THE TREATMENT OF DISEASE

#13546
20090275597
2009-11-05

METHODS OF TREATING CNS DISORDERS

#13547
20090275595
2009-11-05

METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE

#13548
20090275563
2009-11-05

Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy

#13549
20090275559
2009-11-05

Chronotherapeutic formulations of modified-release calcium channel blocker anti-hypertensive drugs in combination with other anti-hypertensive drugs for 24-hour optimal treatment of hypertension, nocturnal hypertension, and/or hypertension with angina

#13550
20090275554
2009-11-05

Aminocarboxylic acid derivative and medicinal use thereof

#13551
20090275552
2009-11-05

Therapy for Treating Resistant Bacterial Infections

#13552
20090275551
2009-11-05

Fluvastatin for the treatment of patients with a history of muscle related side effects with other statins

#13553
20090275549
2009-11-05

Use of picoplatin to treat colorectal cancer

#13554
20090275545
2009-11-05

Medicinal targeted local lipolysis

#13555
20090275541
2009-11-05

Method for treating neurocognitive dysfunction

#13556
20090275540
2009-11-05

Pre-compacted calcium-containing compositions

#13557
20090275529
2009-11-05

METHOD FOR IMPROVING CARDIOVASCULAR RISK PROFILE OF COX INHIBITORS

#13558
20090275528
2009-11-05

Antituberculous composition comprising oxazole compounds

#13559
20090275512
2009-11-05

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

#13560
20090275508
2009-11-05

Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

#13561
20090274784
2009-11-05

PLANT EXTRACT MIXTURES AND THEIR USES

#13562
20090274783
2009-11-05

Herbal compositions and methods for enhancing vital energy and athletic performance

#13563
20090274782
2009-11-05

ANTI-OBESITY AGENT

#13564
20090274781
2009-11-05

ANTI-OBESITY AGENT

#13565
20090274780
2009-11-05

MENOPAUSE TREATMENT COMPOSITION AND REGIMEN

#13566
20090274778
2009-11-05

Compositions Exhibiting Inhibition Of Cyclooxygenase-2

#13567
20090274775
2009-11-05

Lithium combinations, and uses related thereto

#13568
20090274774
2009-11-05

Citrate-based dialysate chemical formulations

#13569
20090274771
2009-11-05

COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISORDERS

#13570
20090274769
2009-11-05

HEALING COMPOSITION

#13571
20090274766
2009-11-05

Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI

#13572
20090274739
2009-11-05

METHODS AND COMPOSITIONS FOR TREATING NEOINTIMAL HYPERPLASIA

#13573
20090274732
2009-11-05

Type-2 Diabetes Combination Wafer

#13574
20090274722
2009-11-05

Therapeutic Composition for the Treatment of BPH and ED

#13575
20090274696
2009-11-05

METHODS FOR TREATING INFLAMMATION

#13576
20090274693
2009-11-05

Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor

#13577
20090274691
2009-11-05

Use of CD25 binding molecules in steroid-resistant patients

#13578
20090274689
2009-11-05

Co-administration of a tissue plasminogen activator, anti-CD11b antibody and anti-CD18 antibody in stroke

#13579
20090274688
2009-11-05

Polynucleotides encoding heavy and light chains of antibodies to OPGL

#13580
20090274676
2009-11-05

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#13581
20090274675
2009-11-05

Migraine tonic

#13582
20090274668
2009-11-05

Combined Regulation of Neural Cell Production

#13583
20090274662
2009-11-05

Methods And Kits For The Treatment Of Inflammatory Bowel Disorder Conditions

#13584
20090274660
2009-11-05

PLURIPOTENT THERAPEUTIC COMPOSITIONS AND USES THEREOF

#13585
20090274656
2009-11-05

Hepatitis C virus inhibitors

#13586
20090274654
2009-11-05

Methods and devices for the sustained release of multiple drugs

#13587
20090274651
2009-11-05

Therapeutic agent for infections, and treatment method using the same

#13588
20090274650
2009-11-05

Inhibitors of aspartyl protease

#13589
20090274632
2009-11-05

Compounds that inhibit (block) bitter taste in composition and use thereof

#13590
20090271217
2009-10-29

Side effect ameliorating combination therapeutic products and systems

#13591
20090270501
2009-10-29

Composition and method for increasing the anabolic state of muscle cells

#13592
20090270498
2009-10-29

Lipoxin compounds and their use in treating cell proliferative disorders

#13593
20090270497
2009-10-29

Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors

#13594
20090270485
2009-10-29

Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site

#13595
20090270437
2009-10-29

Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound Healing

#13596
20090270422
2009-10-29

GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto

#13597
20090270420
2009-10-29

METHODS FOR INHIBITING CARDIAC PAI-1

#13598
20090270419
2009-10-29

COMBINATIONS OF CLASS-I SPECIFIC HISTONE DEACETYLASE INHIBITORS WITH PROTEASOME INHIBITORS

#13599
20090270406
2009-10-29

Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence

#13600
20090270404
2009-10-29

OXYMETHYLENE ARYL COMPOUNDS AND USES THEREOF

#13601
20090270401
2009-10-29

USE OF A DIHYDROIMIDAZOPYRAZOINE DERIVATIVE FOR TREATING OR PREVENTING PAIN

#13602
20090270400
2009-10-29

PAINKILLING ASSOCIATION COMPRISING A DIHYDROIMIDAZOPYRAZINE DERIVATIVE

#13603
20090270397
2009-10-29

Methods and compositions for the treatment of cancers, such as melanomas and gliomas

#13604
20090270377
2009-10-29

Combination cancer chemotherapy

#13605
20090270356
2009-10-29

COMPOSITIONS AND TREATMENTS OF HEART FAILURE IN NON-HUMAN MAMMAL ANIMALS

#13606
20090270354
2009-10-29

Method of removing ticks from the skin and reducing the risk of bites

#13607
20090270346
2009-10-29

Protective gel based on chitosan and oxidized polysaccharide

#13608
20090270341
2009-10-29

PRODUCT COMPRISING A TRANSDUCTION INHIBITOR OF HETEROTRIMERIC G PROTEIN SIGNALS COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER

#13609
20090270316
2009-10-29

HER-2 binding antagonists

#13610
20090269426
2009-10-29

Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions

#13611
20090269425
2009-10-29

Formulation and method for relieving or preventing symptoms associated with uric acid crystals

#13612
20090269423
2009-10-29

Foot-bath agent of Chinese herbal medicine for regulating blood pressure and improving sleep quality

#13613
20090269422
2009-10-29

METHODS FOR CONTROLLING ANGIOGENESIS AND CELL PROLIFERATION

#13614
20090269418
2009-10-29

Compositions and Methods for Inducing Hair Growth

#13615
20090269415
2009-10-29

NOVEL THERAPEUTIC AGENT DERIVED FROM MARINE ORGANISM

#13616
20090269405
2009-10-29

ENZYME MEDIATED DELIVERY SYSTEM

#13617
20090269373
2009-10-29

Saposin C-DOPS: a novel anti-tumor agent

#13618
20090269369
2009-10-29

Ophthalmic composition comprising xanthan gum and glucose

#13619
20090269360
2009-10-29

Therapy targeting cathepsin S

#13620
20090269353
2009-10-29

Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking Agents

#13621
20090269352
2009-10-29

ANTITUMOR AGENT COMPRISING SULFONAMIDE-CONTAINING HETEROCYCLIC COMPOUND COMBINED WITH AN ANGIOGENESIS INHIBITOR

#13622
20090269344
2009-10-29

Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues

#13623
20090269339
2009-10-29

RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY

#13624
20090269337
2009-10-29

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#13625
20090269325
2009-10-29

Methods for treating bleeding disorders using sulfated polysaccharides

#13626
20090269305
2009-10-29

Macrocyclic inhibitors of hepatitis C virus replication

#13627
20090269304
2009-10-29

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#13628
20090264921
2009-10-22

Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof

#13629
20090264530
2009-10-22

COMBINED NSAID AND ACETAMINOPHEN FORMULATION AND METHOD

#13630
20090264522
2009-10-22

METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS WITH A LOW DOSE COMBINATION OF ESCITALOPRAM AND BUPROPION

#13631
20090264520
2009-10-22

LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF

#13632
20090264492
2009-10-22

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A FUNGAL SKIN DISORDER AND A METHOD FOR THE PREPARATION THEREOF

#13633
20090264484
2009-10-22

Methods and Medicaments for Administration of Ibuprofen

#13634
20090264483
2009-10-22

METHODS OF USING PPAR-gamma AGONISTS AND CASPASE-DEPENDENT CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

#13635
20090264479
2009-10-22

Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases

#13636
20090264476
2009-10-22

CB-1 receptor modulator formulations

#13637
20090264467
2009-10-22

Agents and crystals for improving excretory potency of urinary bladder

#13638
20090264454
2009-10-22

COMBINED HYDROCODONE AND ANALGESIC FORMULATION AND METHOD

#13639
20090264439
2009-10-22

Combination of a) N--4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia

#13640
20090264436
2009-10-22

CB-1 receptor modulator formulations

#13641
20090264412
2009-10-22

Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist Therapy

#13642
20090264398
2009-10-22

Method for inducing tumor apoptosis by increasing nitric oxide levels

#13643
20090264395
2009-10-22

Progesterone for the treatment or prevention of spontaneous preterm birth

#13644
20090264388
2009-10-22

Compounds and Methods of Treating Disorders Associated With Activation of Metachromatic Cells

#13645
20090264383
2009-10-22

Inhibitor of Adenylyl Cyclase for Treating a Disorder of the Circadian Rhythm

#13646
20090264382
2009-10-22

Methods for Treating Hematopoietic Neoplasms

#13647
20090264378
2009-10-22

Avermectin compounds and treatment of dermatological disorders in humans therewith

#13648
20090264377
2009-10-22

Anti-neoplastic compositions comprising extracts of black cohosh

#13649
20090264368
2009-10-22

COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN

#13650
20090264367
2009-10-22

5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS

#13651
20090264350
2009-10-22

Kallikrein inhibitors and anti-thrombolytic agents and uses thereof

#13652
20090264347
2009-10-22

Use of Blood Coagulation Factor XIII for Treating Hemophilia A

#13653
20090264342
2009-10-22

COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY

#13654
20090263916
2009-10-22

Antagonists of HMG1 for treating inflammatory conditions

#13655
20090263537
2009-10-22

METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH

#13656
20090263522
2009-10-22

Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2

#13657
20090263514
2009-10-22

Cold and flu tonic

#13658
20090263513
2009-10-22

COSMETIC SKIN LIGHTENING FORMULATION

#13659
20090263509
2009-10-22

ANTIBACTERIAL AGENT AND ANTIBACTERIAL COMPOSITION

#13660
20090263507
2009-10-22

BIOLOGICAL MARKERS AND RESPONSE TO TREATMENT FOR PAIN, INFLAMMATION, NEURONAL OR VASCULAR INJURY AND METHODS OF USE

#13661
20090263504
2009-10-22

METHODS AND COMPOSITIONS FOR PROMOTING ACTIVITY OF ANTI-CANCER THERAPIES

#13662
20090263500
2009-10-22

Composition and method for treating bedsores, cuts and burns

#13663
20090263498
2009-10-22

Pharmaceutical preparations for treating inflammatory diseases

#13664
20090263495
2009-10-22

BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS

#13665
20090263494
2009-10-22

Manzanita

#13666
20090263493
2009-10-22

Method for making synthetic slug slime and medical use of synthetic and or actual slug slime

#13667
20090263488
2009-10-22

PRESSURISED METERED DOSE INHALERS CONTAINING SOLUTIONS OF BETA-2 AGONISTS

#13668
20090263484
2009-10-22

Tissue Engineering Devices and Methods for Luminal Organs

#13669
20090263454
2009-10-22

Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation

#13670
20090263428
2009-10-22

Artificial lymph node for treating cancer

#13671
20090263415
2009-10-22

COMPOSITION FOR SCALP AND HAIR OF SCALP

#13672
20090263401
2009-10-22

USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE

#13673
20090263398
2009-10-22

PHARMACEUTICAL COMBINATIONS

#13674
20090263397
2009-10-22

Combination anti-cancer therapy

#13675
20090263396
2009-10-22

INHIBITORS OF T-DARPP FOR USE IN COMBINATION ANTI-CANCER THERAPIES

#13676
20090263390
2009-10-22

Method of treating cancer by co-administration of anticancer agents

#13677
20090263381
2009-10-22

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTI-IGE ANTIBODY FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#13678
20090263366
2009-10-22

Effects of probiotics on humans and animals under environmental or biological changes

#13679
20090263352
2009-10-22

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS

#13680
20090263349
2009-10-22

METHODS AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS

#13681
20090263345
2009-10-22

Otic compositions for the treatment of infections of the internal and external ear in mammals

#13682
20090263341
2009-10-22

Soft anticholinergic esters

#13683
20090263335
2009-10-22

Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease

#13684
20090259166
2009-10-15

Systems and Methods for Transdermal Photo-Polymerization

#13685
20090258945
2009-10-15

Lipoxin compounds and their use in treating cell proliferative disorders

#13686
20090258937
2009-10-15

Methods for Modulating Tumor Growth and Metastasis

#13687
20090258918
2009-10-15

EP4 receptor agonist, compositions and methods thereof

#13688
20090258896
2009-10-15

Composition comprising at least one higher aliphatic alcohol and an extract of

#13689
20090258860
2009-10-15

XANTHINE DERIVATIVES FOR THE TREATMENT OF VASCULAR DEPRESSION

#13690
20090258845
2009-10-15

Combination dosage forms and therapies for supporting bone health

#13691
20090258844
2009-10-15

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS

#13692
20090258841
2009-10-15

COMPOSITIONS AND METHODS FOR SKIN CARE

#13693
20090258831
2009-10-15

TREATMENT USING NEUBLASTIN POLYPEPTIDES

#13694
20090258829
2009-10-15

NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN

#13695
20090258091
2009-10-15

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

#13696
20090258090
2009-10-15

COLON CLEANSING SOLUTION

#13697
20090258089
2009-10-15

Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides

#13698
20090258086
2009-10-15

Biofilm extracellular polysaccharide solvating system

#13699
20090258084
2009-10-15

Mono and Combination Therapy with a M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Cognitive Disorders in Schizophrenia

#13700
20090258080
2009-10-15

Emu oil and fruit composition

#13701
20090258077
2009-10-15

Composition and method for treating or preventing white spot syndrome virus

#13702
20090258069
2009-10-15

Delivery of LFA-1 antagonists to the gastrointestinal system

#13703
20090258064
2009-10-15

Method of treating drug-resistant cancer

#13704
20090258046
2009-10-15

COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT

#13705
20090258027
2009-10-15

Methods of modulating immune function

#13706
20090258014
2009-10-15

COMBINATION OF HGF INHIBITOR AND EGF INHIBITOR TO TREAT CANCER

#13707
20090257992
2009-10-15

ADJUNCTIVE AGENT FOR LAVAGING THE ALIMENTARY CANAL COMPRISING BUTYRIC ACID BACTERIUM AND/OR LACTIC ACID BACTERIUM

#13708
20090257980
2009-10-15

Anti-virus therapy for respiratory diseases

#13709
20090257969
2009-10-15

Soft anticholinergic zwitterions

#13710
20090257956
2009-10-15

Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation

#13711
20090254104
2009-10-08

METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR

#13712
20090254065
2009-10-08

Simple method of transplanting injectable chordrocyte for autologous chondrocyte transplantation

#13713
20090254021
2009-10-08

Implantable apparatus for administering a therapeutic agent into tissue

#13714
20090253795
2009-10-08

Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation

#13715
20090253788
2009-10-08

Combinations of adapalene and benzoyl peroxide for treating acne lesions

#13716
20090253783
2009-10-08

Production of Delta 9 Tetrahydrocannabinol

#13717
20090253752
2009-10-08

COMBINATION OF DPP-IV INHIBITOR, PPAR ANTIDIABETIC AND METMORFIN

#13718
20090253741
2009-10-08

Alkene piperidine derivatives as antiviral agents

#13719
20090253728
2009-10-08

Methods and Compositions for Treating Nociceptive Pain

#13720
20090253721
2009-10-08

Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor

#13721
20090253702
2009-10-08

Fast acting naratriptan composition

#13722
20090253698
2009-10-08

Brain, spinal and nerve injury treatment

#13723
20090253675
2009-10-08

Pharmaceutical formulation

#13724
20090253665
2009-10-08

METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR

#13725
20090253664
2009-10-08

Combination andolast/glucocorticoids

#13726
20090253649
2009-10-08

Agents containing folic acid, vitamin B6 and vitamin B12, and the use thereof

#13727
20090253647
2009-10-08

2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity

#13728
20090253620
2009-10-08

METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL RADIOSENSITITIVITY IN A SUBJECT

#13729
20090253616
2009-10-08

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#13730
20090253172
2009-10-08

GROWTH FACTOR HOMOLOG ZVEGF4

#13731
20090252827
2009-10-08

Horse feed and methods of treating horses

#13732
20090252817
2009-10-08

Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances

#13733
20090252816
2009-10-08

Inhalable Gaseous Medicament Based On Xenon And Nitrous Oxide

#13734
20090252813
2009-10-08

CerCan: an energy supplement product for boosting the immune system

#13735
20090252808
2009-10-08

Controlled release of biological entities

#13736
20090252790
2009-10-08

TABLET FORMULATION

#13737
20090252786
2009-10-08

Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor

#13738
20090252749
2009-10-08

Carbohydrate content of CTLA4 molecules

#13739
20090252725
2009-10-08

Use of CD23 Antibodies to Treat Malignancies in Patients with Poor Prognosis

#13740
20090252708
2009-10-08

Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof

#13741
20090252692
2009-10-08

Esterified fatty acid composition

#13742
20090252672
2009-10-08

NASAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS

#13743
20090247778
2009-10-01

Phosphorus-containing compounds with polymeric chains, and methods of making and using the same

#13744
20090247643
2009-10-01

Medicinal herbal composition for treating infection

#13745
20090247640
2009-10-01

Antimicrobials having polyquaternary ammoniums and alcohol-bearing amidoamines and methods for their use

#13746
20090247635
2009-10-01

Method for treating anal pruritis and other perianal disorders

#13747
20090247632
2009-10-01

Dermatological compositions and methods

#13748
20090247619
2009-10-01

Cannabinoid-Containing Compositions and Methods for Their Use

#13749
20090247611
2009-10-01

METHOD OF TREATING A CANCER WITH A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND PACLITAXEL

#13750
20090247598
2009-10-01

TREATMENT METHODS

#13751
20090247585
2009-10-01

PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND ESCITALOPRAM

#13752
20090247584
2009-10-01

PHENOXY-PIPERIDINES FOR THE TREATMENT OF DISEASES SUCH AS SCHIZOPHRENIA AND DEPRESSION

#13753
20090247583
2009-10-01

PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND PAROXETINE

#13754
20090247549
2009-10-01

Methods of using saha and bortezomib for treating cancer

#13755
20090247543
2009-10-01

GATIFLOXACIN-CONTAINING AQUEOUS LIQUID PREPARATION

#13756
20090247523
2009-10-01

Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C

#13757
20090247510
2009-10-01

Use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension

#13758
20090247498
2009-10-01

Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications

#13759
20090247496
2009-10-01

Pharmaceutical composition and extract of for enhancing uptake of nutrients

#13760
20090247494
2009-10-01

Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders

#13761
20090247493
2009-10-01

Regimens for Treatment of Conditions Related to Estrogen Deficiency

#13762
20090247490
2009-10-01

Topical compositions containing phosphorylated polyphenols

#13763
20090247487
2009-10-01

Combination Therapy to Treat Hepatitis B Virus

#13764
20090247483
2009-10-01

Method for Treatment of Macular Degeneration

#13765
20090247481
2009-10-01

Compositions and kits for treating influenza

#13766
20090247480
2009-10-01

Anti-cancer therapies

#13767
20090247479
2009-10-01

Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics

#13768
20090247476
2009-10-01

MANNITOL AND/OR PROLINE FOR PREVENTION AND TREATMENT OF AGEING RELATED SYMPTOMS

#13769
20090247469
2009-10-01

Ophthalmic compositions comprising a dipeptide

#13770
20090247466
2009-10-01

NEUROPROTECTIVE INTEGRIN-BINDING PEPTIDE AND ANGIOPOIETIN-1 TREATMENTS

#13771
20090247453
2009-10-01

Kallikrein Inhibitors and Anti-thrombolytic Agents and Uses Thereof

#13772
20090247452
2009-10-01

Pharmaceutical formulations for reducing pain

#13773
20090246314
2009-10-01

EQUINE WHOLE FOOD SUPPLEMENTS

#13774
20090246301
2009-10-01

METHOD FOR TREATING IRRITABLE BOWEL SYNDROME AND OTHER FUNCTIONAL GASTROINTESTINAL DISORDERS

#13775
20090246300
2009-10-01

Adaptogenic tea

#13776
20090246299
2009-10-01

Fat composition

#13777
20090246291
2009-10-01

METHOD AND COMPOSITIONS FOR TREATMENT OF CANCER

#13778
20090246290
2009-10-01

Lipid metabolism improving agent containing hydrogen molecules

#13779
20090246276
2009-10-01

Pharmaceutical Compositions

#13780
20090246271
2009-10-01

Combination of ceramide and gemcitabine for inducing cell death and uses thereof in treating cancer

#13781
20090246265
2009-10-01

ABUSE DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS

#13782
20090246251
2009-10-01

Peptide compositions for coating metal medical devices with vancomycin

#13783
20090246250
2009-10-01

COATING COMPOSITIONS HAVING IMPROVED PERFORMANCE

#13784
20090246249
2009-10-01

COATING COMPOSITIONS HAVING IMPROVED PERFORMANCE

#13785
20090246248
2009-10-01

COATING COMPOSITIONS HAVING IMPROVED PERFORMANCE

#13786
20090246246
2009-10-01

PROCESSES FOR RELIEVING BLOCKED VESSELS AND PRODUCTS THEREBY

#13787
20090246232
2009-10-01

Pharmaceutical composition

#13788
20090246231
2009-10-01

Formulations containing borojo

#13789
20090246213
2009-10-01

VACCINE COMPRISING A POLYNUCLEOTIDE ENCODING AN ANTIGEN RECOGNIZED BY A CD4+ HELPER T-CELL AND A POLYNUCLEOTIDE ENCODING A TUMOR SPECIFIC OR ASSOCIATED ANTIGEN RECOGNIZED BY A CD8+ CTL

#13790
20090246208
2009-10-01

METHODS FOR PREVENTING AND TREATING CANCER METASTASIS AND BONE LOSS ASSOCIATED WITH CANCER METASTASIS

#13791
20090246197
2009-10-01

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)

#13792
20090246196
2009-10-01

COMBINED TARGETED THERAPY FOR THE TREATMENT OF PROLIFERATIVE DISEASE

#13793
20090246173
2009-10-01

TREATMENT WITH ANTI-VEGF ANTIBODIES

#13794
20090246172
2009-10-01

COMPOSITIONS COMPRISING EPOTHILONES AND THEIR USE FOR THE TREATMENT OF CARCINOID SYNDROME

#13795
20090246170
2009-10-01

Therapeutic Agent For Alzheimer's Disease

#13796
20090246168
2009-10-01

Antitumoral treatments

#13797
20090246153
2009-10-01

COSMETIC COMPOSITIONS FOR THE INHIBITION OF REACTIVE OXYGEN SPECIES

#13798
20090246152
2009-10-01

NARACTIN COMPOSITIONS FOR THE INHIBITION OF REACTIVE OXYGEN SPECIES

#13799
20090246146
2009-10-01

HALIDES IN THE TREATMENT OF PATHOGENIC INFECTION

#13800
20090246136
2009-10-01

Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration